4-(Trifluoromethoxy)benzylamine → HCID 69082711, compound
Reaction equation
[F:1][C:2]([F:13])([F:12])[O:3][C:4]1[CH:9]=[CH:8][C:7]([CH2:10][NH2:11])=[CH:6][CH:5]=1.[F:14][C:15]1[CH:22]=[CH:21][CH:20]=[C:19]([O:23][CH3:24])[C:16]=1[CH:17]=O.[Na].C(OCC)(=O)[CH2:27][C:28]([C:30](OCC)=[O:31])=[O:29]>>[F:14][C:15]1[CH:22]=[CH:21][CH:20]=[C:19]([O:23][CH3:24])[C:16]=1[CH:17]1[N:11]([CH2:10][C:7]2[CH:6]=[CH:5][C:4]([O:3][C:2]([F:12])([F:13])[F:1])=[CH:9][CH:8]=2)[C:30](=[O:31])[CH:28]([OH:29])[CH2:27]1Participants
4
Procedure
Prepared according to general procedure 10A (GP10A) and general procedure 10B (GP10B) using commercially available (4-(trifluoromethoxy)phenyl)methanamine, commercially available 2-fluoro-6-methoxybenzaldehyde, and commercially available diethyl oxalacetate sodium salt. LC-MS (conditions A): tR=0.80 min.; [M+H]+: 400.22 g/mol.
Workup
- customPrepared
Sources & evidence
- ORD record
- ord-fb725614441c4d00bb8c8f390f94b4f2
- Source dataset
- uspto-grants-2016_01
- Patent number
- US09242970B2
Reaction notes
Loading…